Buchumschlag

Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopenia guided by therapeutic drug monitoring

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Shuyue Dong, Zhifa Wang, Nan Wang, Jingyao Ma, Jinxi Meng, Zhenping Chen, Runhui Wu, Xiaoling Cheng
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	British Journal of Haematology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The early and rapid response to daratumumab in children with chronic refractory immune thrombocytopenia from a referral single centre of China
von: Yu Hu, et al.
Veröffentlicht: (2024)

Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
von: Zhifa Wang, et al.
Veröffentlicht: (2024)

Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?
von: Clara Lo
Veröffentlicht: (2024)

Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid‐resistant immune thrombocytopenia
von: Yuncui Yu, et al.
Veröffentlicht: (2025)

Interplay of leucocyte–platelet complexes and clinical response to eltrombopag in immune thrombocytopenia patients
von: Rubén Osuna‐Gómez, et al.
Veröffentlicht: (2024)

Predictors of response to emergent therapies in paediatric immune thrombocytopenia
von: Candelaria O'Farrell, et al.
Veröffentlicht: (2025)

Efficacy and safety of eltrombopag in combination with dexamethasone as first‐line treatment in adult patients with newly diagnosed immune thrombocytopenia
von: Annaïse J. Jauch, et al.
Veröffentlicht: (2026)

Long‐term efficacy and safety of hetrombopag in paediatric patients with immune thrombocytopenia
von: Jin‐Hua Wang, et al.
Veröffentlicht: (2026)

Efficacy and safety of romiplostim and eltrombopag in management of thrombocytopenia in Wiskott–Aldrich syndrome patients
von: Anna Ogneva, et al.
Veröffentlicht: (2025)

Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial
von: Qi Liu, et al.
Veröffentlicht: (2025)

Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India
von: Niteesh Bharadwaj, et al.
Veröffentlicht: (2024)

Spotlight on eltrombopag concentration in pediatric immune thrombocytopenia: A single‐center observational study in China
von: Shuyue Dong, et al.
Veröffentlicht: (2024)

Short‐ and long‐term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia
von: Boris Sorin, et al.
Veröffentlicht: (2026)

Real‐world treatment patterns and outcomes among patients with immune thrombocytopenia ( ITP ) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL ‐ AVA 3.5 study
von: Caroline Piatek, et al.
Veröffentlicht: (2026)

Feasibility of plasma proteomics in patients with immune thrombocytopenia
von: Rick Kapur
Veröffentlicht: (2024)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia—Response
von: Xiang Liu, et al.
Veröffentlicht: (2024)

Acute stroke in children with immune thrombocytopenia: A systematic review and meta‐analysis
von: Andrew Ly, et al.
Veröffentlicht: (2025)

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia
von: Zhenyu Liu, et al.
Veröffentlicht: (2026)

Anti‐ CD38 therapy in immune thrombocytopenia ( ITP )
von: Waleed Ghanima, et al.
Veröffentlicht: (2026)

When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?
von: Sydney Dubois, et al.
Veröffentlicht: (2024)

Cognitive impairment among patients with chronic immune thrombocytopenia
von: David J. Kuter, et al.
Veröffentlicht: (2024)

Nicotinamide enhances Treg differentiation by promoting Foxp3 acetylation in immune thrombocytopenia
von: Ju Li, et al.
Veröffentlicht: (2024)

Longitudinal evaluation of adverse events due to steroid use in primary immune thrombocytopenia: A population‐based study
von: Jiaan‐Der Wang, et al.
Veröffentlicht: (2024)

Unveiling the responsible antigen in vaccine‐induced immune thrombotic thrombocytopenia
von: Chika Edward Uzoigwe
Veröffentlicht: (2025)

COVID‐19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence
von: Hinpetch Daungsupawong, et al.
Veröffentlicht: (2024)

Longitudinal plasma proteomics in romiplostim‐treated patients with immune thrombocytopenia
von: Vivianne S. Nelson, et al.
Veröffentlicht: (2025)

Treatment of refractory/relapsed Diamond–Blackfan anaemia with eltrombopag
von: Brynn B. Duncan, et al.
Veröffentlicht: (2024)

CD19+IL‐10+ regulatory B cells induced by IL‐12p35 regulates functional T‐cell subsets in patients with immune thrombocytopenia
von: Fanli Hua, et al.
Veröffentlicht: (2025)

Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia
von: Tian‐shu Yu, et al.
Veröffentlicht: (2025)

Comprehensive analysis and prediction model of mitophagy and ferroptosis in primary immune thrombocytopenia
von: Jiani Mo, et al.
Veröffentlicht: (2024)

Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: Identification of a novel pathogenic mutation
von: Xinmiao Qu, et al.
Veröffentlicht: (2024)

CD19 chimeric antigen receptor‐T cell therapy in murine immune thrombocytopenia
von: Fengjiao Han, et al.
Veröffentlicht: (2025)

Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT)
von: Vinita Dhir, et al.
Veröffentlicht: (2024)

Incidence of systemic lupus erythematosus in patients with immune thrombocytopenia: A nationwide study
von: Malin Rasmussen, et al.
Veröffentlicht: (2025)

Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study
von: LiQin Cao, et al.
Veröffentlicht: (2026)

Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort study
von: Qing Wen, et al.
Veröffentlicht: (2024)

PF4‐associated immune thrombocytopenia and thrombosis (PITT)—More than heparin and vaccines
von: Michael Makris
Veröffentlicht: (2025)

A multicentre randomized open‐label phase 2 trial of dexamethasone plus glycyrrhizinate versus dexamethasone in newly diagnosed immune thrombocytopenia
von: Haoyi Wang, et al.
Veröffentlicht: (2026)

Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study
von: Reyes Jiménez‐Bárcenas, et al.
Veröffentlicht: (2024)

Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy
von: Pauline Durand, et al.
Veröffentlicht: (2024)